Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Natera (DE:45E)
BERLIN:45E
Natera (45E) Stock Price & Analysis
3 Followers
45E Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€35.20 - €90.50
Previous Close€84.5
Volume0.00
Average Volume (3M)67.00
Market Cap
€10.47B
Enterprise Value€10.62B
Total Cash (Recent Filing)$267.80M
Total Debt (Recent Filing)$431.31M
Price to Earnings (P/E)N/A
Beta0.47
Next Earnings
May 02, 2024EPS Estimate
-€0.66Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding120,757,877
10 Day Avg. Volume0
30 Day Avg. Volume67
Standard Deviation0.27
R-Squared0.07
Alpha0.03
Financial Highlights & Ratios
Price to Book (P/B)14.46
Price to Sales (P/S)37.80
Price to Cash Flow (P/CF)-47.60
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue10.74
Enterprise Value/Gross Profit28.97
Enterprise Value/Ebitda-22.90
Forecast
1Y Price Target
€95.77Price Target Upside13.34% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering13
Natera News
Bulls Say, Bears Say
Bulls Say
Financial PerformanceNatera delivered very strong metrics across the board, reaffirming its position as a top pick with a Buy rating and an increased price target.
Guidance And Growth PotentialThe company provided 2024 revenue guidance that was meaningfully ahead of our estimate and consensus, indicating potential for revenue and gross margin outperformance.
Product And Market ExpansionNatera received Medicare coverage for Signatera in two new indications, potentially expanding its market.
Bears Say
Financial PerformanceUS credit card delinquencies jumped significantly, pointing to increasing consumer difficulty in repaying their credit obligations.
Legal And Competitive LandscapeThe trial follows NTRA’s success in a separate lawsuit filed by CareDx, which invalidated all of CDNA’s asserted patents.
Market CompetitionDownside risks include competitive risks: Signatera faces material competition in the MRD market from other firms.
---
Options Prices
Currently, No data available
---
Ownership Overview
0.00% Insiders
0.00% Mutual Funds
0.99% Other Institutional Investors
99.01% Public Companies and
Individual Investors
45E FAQ
What was Natera’s price range in the past 12 months?
Natera lowest stock price was €35.20 and its highest was €90.50 in the past 12 months.
What is Natera’s market cap?
Currently, no data Available
When is Natera’s upcoming earnings report date?
Natera’s upcoming earnings report date is May 02, 2024 which is in 3 days.
How were Natera’s earnings last quarter?
Natera released its earnings results on Feb 28, 2024. The company reported -€0.607 earnings per share for the quarter, beating the consensus estimate of -€0.719 by €0.112.
Is Natera overvalued?
According to Wall Street analysts Natera’s price is currently Undervalued.
Does Natera pay dividends?
Natera does not currently pay dividends.
What is Natera’s EPS estimate?
Natera’s EPS estimate is -€0.66.
How many shares outstanding does Natera have?
Currently, no data Available
What happened to Natera’s price movement after its last earnings report?
Natera reported an EPS of -€0.607 in its last earnings report, beating expectations of -€0.719. Following the earnings report the stock price went up 12.23%.
Which hedge fund is a major shareholder of Natera?
Among the largest hedge funds holding Natera’s share is Farallon Capital Management, L.L.C.. It holds Natera’s shares valued at 218M.
---
Natera Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
€95.77 (13.34% Upside)
€95.77 (13.34% Upside)
Blogger Sentiment
Bullish
DE:45E Sentiment 75%
Sector Average 70%
Sector Average 70%
Insider Transactions
Bought Shares
Worth $1.8M over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bearish
Bullish news 0%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
84.16%
12-Months-Change
Fundamentals
Return on Equity
-59.11%
Trailing 12-Months
Asset Growth
3.01%
Trailing 12-Months
Company Description
Natera
Natera, Inc. engages in the discovery, development, and commercialization of genetic testing services. It offers Panorama Non-Invasive Prenatal Test, Horizon Carrier Screening, Spectrum Pre-implantation Genetic Screening and Spectrum Pre-implantation Genetic Diagnosis, Anora Products of Conception and Non-Invasive Paternity Testing. The company was founded by Matthew Rabinowitz and Jonathan Sheena in November 2003 and is headquartered in San Carlos, CA.
---
45E Company Deck
---
45E Earnings Call
Q4 2024
0:00 / 0:00
---
45E Stock 12 Months Forecast
Average Price Target
€95.77
▲(13.34% Upside)
Technical Analysis
Best Analysts Covering 45E
1 Year
1 Year Success Rate
14/17 ratings generated profit
1 Year Average Return
+38.41%
reiterated a buy rating 2 months ago
Copying David Westenberg's trades and holding each position for 1 Year would result in 82.35% of your transactions generating a profit, with an average return of +38.41% per trade.
---